Search

everythinglearnresearchcommunity

for

Search:↓

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

Ginseng and its compounds may help hair growth and prevent hair loss, but more human trials are needed to confirm this.

Hair follicle biology advancements may lead to better hair growth disorder treatments.

Molecular diagnostics help identify genetic defects causing endocrine diseases, improving diagnosis and treatment options.

Canine epidermal neural crest stem cells could be a promising treatment for spinal cord injuries in dogs.

People with Alopecia Areata are more likely to have autoimmune diseases, inflammatory diseases, and mental health issues like anxiety and depression.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Certain gene variations in EGF and EGFR may increase the risk of alopecia areata in Koreans.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Higher antigliadin antibody levels are linked to alopecia areata severity.

The 2003 guidelines suggest that while some treatments can regrow hair in alopecia areata, none alter the disease's progression, and wigs may be the best option for extensive hair loss.

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Interferon gamma alone can't cause alopecia areata in C3H/HeJ mice.

Fractional lasers and microneedling, combined with topical agents, could potentially treat Alopecia Areata effectively, but more research is needed due to limited data.

Most children with a common hemochromatosis genotype had elevated iron levels but no severe symptoms.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

TGF-β2 plays a key role in human hair growth and development.

Lamivudine might reverse hair graying and needs more research for potential treatments.

Fat cells are important for healthy skin, hair growth, and healing, and changes in these cells can affect skin conditions and aging.

Leontopodium alpinum extract may help reduce hair shedding by keeping hair in the growth phase longer.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

The ZIP7 gene helps control zinc levels in cells by moving zinc from the Golgi apparatus to the cytoplasm.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

The conclusion is that recognizing hair growth cycles can improve the precision of dietary and health assessments from hair analysis.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

Mesenchymal stem cell therapy may help treat alopecia areata by promoting hair growth and reducing inflammation.